FDA exempts follow-on genetic risk tests from 510(k) requirements

FDA published an order Tuesday that exempts subsequent OTC tests under a genetic health risk

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE